Study of the circulation of dengue, yellow fever, and West Nile viruses in Guinea: implications for achieving the health objectives of the Simandou 2040 program Authors: Mamadou Boundoukhoura Bah, Mariama Diallo, Alphonse Keller Konkon, Mamadou Morou Barry, Aissatou Boiro, Ibrahima Baϊlo Diallo, Ibrahima Sory Sow, Thierno Amadou Labe Balde, Salifou Talasson Bangoura, Kirill Zakharov, Gbago Onivogui, Sanaba Boumbaly, Ekaterina Naidenova, Mohamed Sahar Traore Published: 2026 ABSTRACT BackgroundDiseases such as dengue, yellow fever and West Nile virus, which are transmitted by arthropods, pose public health problems in tropical and subtropical regions. Like many West African countries, Guinea possesses all the conditions conducive to the circulation of these viruses. These include local ecology and climate, as well as the presence of vectors that transmit these viruses. Despite their medical importance, these viruses have received limited study, and up-to-date information on their circulation remains scarce. In this context, the present study examined the prevalence of these three arboviruses (DENV, YFV and WNV) in human and vector populations.MethodologyThis study covered 18 Guinea prefectures, which are spread across the country's four ecological zones. The study was conducted from 27 May to 27 November 2024. In health centers selected in each prefecture, 5 ml samples of venous blood were collected from asymptomatic patients aged 1–90 years who had visited for consultations and had given their consent. Additionally, mosquitoes were collected via an "AMPLECTA MOSQUITO TRAP" light trap. Two ELISA tests were performed on the blood samples: the first for detection and the second for confirmation of the presence of these viruses in human serum. The mosquito samples were analyzed to determine diversity, and real-time PCR was employed to check for viral infection in the vectors following viral RNA extraction via the RIBO-prep AmpliSens® Kit.ResultsSerological evidence of exposure to all three viruses in the eighteen surveyed prefectures indicates their widespread distribution across the country. The highest seroprevalence of dengue virus antibodies was observed in N’Zerekore (43.9% [38.5–49.4%]), whereas the highest seroprevalence of yellow fever virus antibodies was recorded in Kankan Prefecture (54.7%; 95% CI: 41.5–67.3). In Forecariah, up to 53.0% (95% CI: 42.4–63.4) of participants were seropositive for West Nile virus antibodies. Seropositivity for these arboviruses was more frequently observed among adults. Higher seroprevalence of dengue and yellow fever antibodies was also observed among farmers and livestock breeders. Higher seroprevalence of dengue and yellow fever antibodies was also observed among farmers and livestock breeders. No dengue or yellow fever infections were detected in the vectors, whereas the Culex quinquefasciatus population was found to be infected with WNV.ConclusionThis study provides serological evidence of exposure to dengue, yellow fever, and West Nile viruses across all the ecological regions of the Republic of Guinea. In addition, antibodies against these viruses were detected in human populations, and arbovirus-positive mosquito pools were identified during entomological investigations. Evidence of West Nile virus was also detected in mosquito pools containing Culex quinquefasciatus, suggesting a possible role of this species in the local transmission cycle. Adult farmers and livestock breeders appear to be at the greatest risk of contracting dengue and yellow fever. These results highlight the need for an integrated arbovirus surveillance system in Guinea. This system must combine serological surveillance with entomological surveys to support the public health objectives of the Simandou 2040 program. Introduction Arboviral diseases, including dengue, yellow fever, chikungunya, West Nile virus, and Zika, pose a global threat to public health [1, 2]. These diseases are classified as emerging and reemerging; they are transmitted by mosquitoes, have spread to new geographic areas and have intensified in recent decades [3, 4]. The viruses responsible for these diseases belong to the Flavivirus and Alphavirus genera and are spread by blood-feeding arthropods, primarily mosquitoes of the Aedes and Culex genera [4, 5]. Notable viruses in these genera include dengue virus (DENV), yellow fever virus (YFV), West Nile virus (WNV), Zika virus (ZIKV), and chikungunya virus (CHIKV), which are of major medical importance in humans [2]. Dengue fever typically presents as a simple fever, but it can progress to hemorrhagic fever. Yellow fever causes severe liver damage. West Nile virus can lead to severe neurological disorders, and Zika is often associated with neurological and congenital disorders [6]. On the other hand, chikungunya causes severe joint pain that can sometimes become chronic [7]. These diseases are characterized by high epidemic potential, rapid geographic spread, and increasing pressure on health systems worldwide [8]. Furthermore, global statistics rank dengue as the most significant arbovirus disease. More than 100 to 400 million cases are reported worldwide each year, including 3.18 million cases and 28,000 deaths in 2019 [2]. Moreover, chikungunya and Zika account for 693,000 and 500,000 cases per year, respectively. Yellow fever accounts for an estimated 130,000 cases and 30,000 deaths per year. Although less well documented, the West Nile virus causes an estimated 2,588 severe cases each year [2]. These arboviruses are present in Africa and often manifest as recurrent epidemics [9, 10]. In Africa, a total of 245,176 suspected dengue cases were reported in 2023, including 18,697 confirmed cases and 771 deaths [11]. The majority of fatalities were recorded in Burkina Faso, which alone accounted for 688 dengue-related deaths. In the same year, 104 confirmed cases of yellow fever and 39 associated deaths were reported. Nigeria was the most affected country, with 21 deaths, followed by Cameroon (6 deaths), the Central African Republic and Guinea (4 deaths each), and Congo (2 deaths). Regarding West Nile virus, 12 confirmed cases and 2 deaths were reported across Africa. Tunisia accounted for 10 cases and one death, whereas Namibia and Senegal, the two other affected countries, each reported a single case [11]. Most epidemics linked to these diseases occur in West Africa [12]. These findings demonstrate why this region deserves special attention when addressing this issue. Furthermore, dengue outbreaks have frequently been reported in countries bordering Guinea, such as Senegal and Côte d'Ivoire, which significantly contribute to the regional burden [13, 14]. The intensification of the transmission of these arboviruses, as well as the increased risk of epidemics, is driven by several factors. These include rapid urbanization, strong population growth, and environmental changes. These changes have contributed to the abundance and spread of vectors, such as Aedes aegypti, Aedes albopictus, and Culex quinquefasciatus [15–19]. The circulation of arboviruses in Guinea has been documented for several decades through clinical surveys and serological studies conducted in various regions [20, 21]. Between 2000 and 2024, up to 947 confirmed cases of yellow fever and 284 related deaths were reported in Guinea. Regarding dengue, two confirmed cases, including one death, were recorded between 2023 and 2024 [21]. To date, no study has documented the circulation of West Nile virus in Guinea. However, these data are often incomplete and rarely address the distribution of infection among mosquito vectors, leaving national epidemiological data on arbovirus circulation incomplete. Increased deforestation in the Republic of Guinea creates climatic conditions conducive to vector proliferation, leaving the country vulnerable to recurrent viral epidemics [22]. Strengthening integrated arbovirus surveillance is a priority. In this context, this study was designed on the basis of a combined approach integrating human serological investigations and entomological surveillance. This study assessed the circulation of dengue, yellow fever, and West Nile viruses in the human population and among the vectors involved in their transmission. This work fully aligns with the “One Health” approach, which recognizes the interdependence of environmental factors, vector ecology, and human health. In this context, seroprevalence is a crucial indicator for evaluating the population's cumulative exposure and identifying silent or underdiagnosed viral circulation. This study aimed to investigate the circulation of dengue, yellow fever, and West Nile viruses in Guinea in both human populations and mosquito vectors to elucidate their transmission dynamics. The findings are expected to generate evidence that will guide public health authorities and contribute to the objectives of the Simandou 2040 program, particularly those related to strengthening health systems, improving disease surveillance, and enhancing the prevention and control of arboviral diseases in the Republic of Guinea. Methodology Study design and site This cross-sectional study was conducted over a seven-month period, from May 27 to November 27, 2024. This study incorporated sero-epidemiological and entomological components and assessed the circulation of arboviruses among the human population and vectors. Investigations were conducted in 18 prefectures spread across four ecological zones: Lower Guinea (Conakry, Coyah, Dubreka, Forecariah, Kindia, and Telemele); Middle Guinea (Dalaba, Labe, Mamou, Pita, and Koubia); Upper Guinea (Kankan, Siguiri, Kouroussa, and Dabola); and Forest Guinea (N’Zerekore, Gueckedou, and Kissidougou) in the Republic of Guinea (Fig. 1).Fig. 1Map of the study site Map of the study site Study population The prefectures were selected through random sampling from the national database of prefectures. Furthermore, within the selected prefectures, prefectural hospitals were designated as sampling sites for data collection. This study included asymptomatic patients (i.e., presenting with neither fever nor signs of acute infection) who were seen in prefectural hospitals during the study period and had never been vaccinated against yellow fever. Participants who reported not having been vaccinated against yellow fever were verified based on their medical records or vaccination cards before being included in the study. Eligible patients were those who agreed to participate after receiving detailed information about the study’s objectives and procedures. They also had to reside in the study area, be between one and 90 years of age, and never have received a yellow fever vaccine. Sampling and processing of vector mosquitoes Vector mosquito sampling was conducted in six prefectures distributed across the country’s major ecological zones. Specifically, Lower Guinea was represented by Conakry and Kindia, Middle Guinea by Mamou and Labe, Upper Guinea by Kankan, and Forest Guinea by N’Zerekore. Four "AMPLECTA MOSQUITO TRAP" light traps were installed outside selected households in each prefecture from 7:00 p.m. to 7:00 a.m. After collection, the samples were identified with Huang [23] and Coetzee et al.[24] morphological keys. The identified species were placed in labeled tubes according to their species, collection site, and collection date. The samples were stored on dry ice at temperatures below − 20 °C and transported to the laboratory while maintaining the cold chain. Laboratory analysis of mosquito samples Pools of 30 individuals were created by species and collection site. The nucleic acids were isolated using a set of “RIBO-Prep” reagents, and the reverse transcription reaction was performed with “REVERTA-L” (both drugs manufactured by the Central Research Institute of Epidemiology, Russia). The obtained material was tested by reverse transcription polymerase chain reaction (RT-PCR) using reagent kits to identify the RNAs of the following pathogens: DENV ("AmpliSens® Dengue virus type –Fl"), YFV ("AmpliSens® YFV -FL") and "AmpliSens® WNV-FL" (Central Research Institute of Epidemiology, Russia). Blood sample collection and processing in humans Blood collection A 5 mL venous blood sample was collected by qualified healthcare personnel under strict biosafety conditions. Steriles, single-use supplies and appropriate personal protective equipment were used. After the samples were allowed to acclimate at room temperature, they were centrifuged at 10 to 3,000 rpm to obtain the serum. The serum was then divided into labeled tubes for subsequent analysis. Laboratory analysis of blood samples Serum samples were tested for the presence of virus-specific IgG antibodies via indirect ELISA performed according to the manufacturer’s instructions (‘BIOSERVIS”, Russia). Optical density values were interpreted via predefined cutoff criteria to determine seropositivity. Owing to the known serological cross-reactivity among flaviviruses, all samples that were initially positive for IgG against dengue virus (DENV), West Nile virus (WNV), or yellow fever virus (YFV) were retested via commercial ELISA kits (EUROIMMUN, Germany) that were specific to each virus to validate the results. Statistical analyses The data were analyzed via R software (version 4.5.2). A descriptive analysis was conducted on the basis of both the quantitative and qualitative variables of the study. These variables were described in terms of counts and proportions. To improve the robustness of the estimates, we calculated 95% confidence intervals for each proportion via the Wilson method, which is recognized for its superior performance, particularly for small sample sizes or proportions close to 0 or 1. To assess cases of coinfection, we calculated the proportion of coinfected individuals across all samples. Confidence intervals (95% CI) were calculated via the binomial approximation (Wald type). Species richness (S) was determined by prefecture and corresponds to the number of mosquito species collected per site. A principal component analysis (PCA) was performed to examine the relationship between occupation and infection with the three viruses studied. For the study of vector mosquito diversity, the relative abundance (Pi) of each species was calculated for each site via the following formula: Pi = ni/N, where ni is the number of individuals of species i, N is the total number of individuals encountered, and i ranges from 1 to S for each study site. The results are presented in summary tables and graphs that incorporate both the observed proportions and their confidence intervals. This facilitated the interpretation and comparison of indicators. Results Overall distribution of seroreactivity to dengue virus, yellow fever virus, and West Nile virus in the human population The overall seroprevalence rates of antibodies reactive to dengue, yellow fever, and West Nile virus infections in the human population were 18.22%, 23.86% and 25.36%, respectively (Fig. 2).Fig. 2Overall distributions of the prevalence rates of antibodies reactive to dengue virus, yellow fever virus, and West Nile virus in the Republic of Guinea Overall distributions of the prevalence rates of antibodies reactive to dengue virus, yellow fever virus, and West Nile virus in the Republic of Guinea Distribution of seroreactivity to dengue virus, yellow fever virus, and West Nile virus by prefecture in the human population Analysis of ELISA-based seroreactivity to dengue virus, yellow fever virus, and West Nile virus in the human population revealed marked geographical heterogeneity across prefectures (Table 1). The seroprevalence of antibodies reactive to dengue virus ranged from 0% [0–4.4] in Forecariah to 43.9% [38.5–49.4] in N'Zerekore. Elevated seroreactivity was also observed in the prefectures of Siguiri (22.9% [12.1%-39%]), Kissidougou (24.3% [17.9%-32%]), Kankan (35.8% [24.3%-49.3%]), and Gueckedou (27.6% [19.3%-37.8%]). For the West Nile virus, seroprevalence ranged from 5.7% [3.4–9.3] in Conakry to 53% [42.4–63.4] in Forecariah. Prefectures with seroprevalence estimates above 30% included Kankan (35.8% [24.3–49.3]), Koubia (37.1% [23.2–53.7]), Kouroussa (30.8% [12.7–57.6]), Labe (37.9% [28.8–47.9]), Mamou (34.9% [26.5–44.4]), and Siguiri (34.3% [20.8–50.8]). These rates are evidence of the circulation of this virus, which has long been overlooked. Seroreactivity to yellow fever virus ranged from 5.7% (1.6–18.6) in Koubia to 54.7% (41.5–67.3) in Kankan. Overall, these findings suggest widespread exposure to, or circulation of the three viruses across the 18 surveyed prefectures.Table 1Seroprevalence of ELISA-reactive antibodies to dengue virus, yellow fever virus, and West Nile virus by prefecturePrefecturesVirusN_testedPositiveProportions (%) [IC 95%]Dengue247145.7 [3.4–9.3]ConakryWNV247145.7 [3.4–9.3]Yellow_Fever2478032.4 [26.9–38.5]Dengue117119.4 [5.3–16.1]CoyahWNV11776 [2.9–11.8]Yellow_Fever1174235.9 [27.8–44.9]Dengue2015 [0.9–23.6]DabolaWNV20945 [25.8–65.8]Yellow_Fever201050 [29.9–70.1]Dengue60610 [4.7–20.1]DalabaWNV602541.7 [30.1–54.3]Yellow_Fever6058.3 [3.6–18.1]Dengue9822 [0.6–7.1]DubrekaWNV983030.6 [22.4–40.3]Yellow_Fever983535.7 [26.9–45.6]Dengue8300 [0–4.4]ForecariahWNV834453 [42.4–63.4]Yellow_Fever832934.9 [25.6–45.7]Dengue872427.6 [19.3–37.8]GueckedouWNV872528.7 [20.3–39]Yellow_Fever8755.7 [2.5–12.8]Dengue531935.8 [24.3–49.3]KankanWNV531935.8 [24.3–49.3]Yellow_Fever532954.7 [41.5–67.3]Dengue1783016.9 [12.1–23]KindiaWNV1783921.9 [16.5–28.5]Yellow_Fever1788849.4 [42.2–56.7]Dengue1403424.3 [17.9–32]KissidougouWNV1402618.6 [13–25.8]Yellow_Fever1401410 [6.1–16.1]Dengue35617.1 [8.1–32.7]KoubiaWNV351337.1 [23.2–53.7]Yellow_Fever3525.7 [1.6–18.6]Dengue13215.4 [4.3–42.2]KouroussaWNV13430.8 [12.7–57.6]Yellow_Fever13753.8 [29.1–76.8]Dengue951111.6 [6.6–19.6]LabeWNV953637.9 [28.8–47.9]Yellow_Fever951616.8 [10.6–25.6]Dengue1062018.9 [12.6–27.4]MamouWNV1063734.9 [26.5–44.4]Yellow_Fever1061817 [11–25.3]Dengue31013643.9 [38.5–49.4]N_ZerekoreWNV3107122.9 [18.6–27.9]Yellow_Fever310309.7 [6.9–13.5]Dengue4648.7 [3.4–20.3]PitaWNV461328.3 [17.3–42.5]Yellow_Fever46613 [6.1–25.7]Dengue35822.9 [12.1–39]SiguiriWNV351234.3 [20.8–50.8]Yellow_Fever351748.6 [33–64.4]Dengue8311.2 [0.2–6.5]TelemeleWNV8378.4 [4.1–16.4]Yellow_Fever832530.1 [21.3–40.7] Table 1Seroprevalence of ELISA-reactive antibodies to dengue virus, yellow fever virus, and West Nile virus by prefecturePrefecturesVirusN_testedPositiveProportions (%) [IC 95%]Dengue247145.7 [3.4–9.3]ConakryWNV247145.7 [3.4–9.3]Yellow_Fever2478032.4 [26.9–38.5]Dengue117119.4 [5.3–16.1]CoyahWNV11776 [2.9–11.8]Yellow_Fever1174235.9 [27.8–44.9]Dengue2015 [0.9–23.6]DabolaWNV20945 [25.8–65.8]Yellow_Fever201050 [29.9–70.1]Dengue60610 [4.7–20.1]DalabaWNV602541.7 [30.1–54.3]Yellow_Fever6058.3 [3.6–18.1]Dengue9822 [0.6–7.1]DubrekaWNV983030.6 [22.4–40.3]Yellow_Fever983535.7 [26.9–45.6]Dengue8300 [0–4.4]ForecariahWNV834453 [42.4–63.4]Yellow_Fever832934.9 [25.6–45.7]Dengue872427.6 [19.3–37.8]GueckedouWNV872528.7 [20.3–39]Yellow_Fever8755.7 [2.5–12.8]Dengue531935.8 [24.3–49.3]KankanWNV531935.8 [24.3–49.3]Yellow_Fever532954.7 [41.5–67.3]Dengue1783016.9 [12.1–23]KindiaWNV1783921.9 [16.5–28.5]Yellow_Fever1788849.4 [42.2–56.7]Dengue1403424.3 [17.9–32]KissidougouWNV1402618.6 [13–25.8]Yellow_Fever1401410 [6.1–16.1]Dengue35617.1 [8.1–32.7]KoubiaWNV351337.1 [23.2–53.7]Yellow_Fever3525.7 [1.6–18.6]Dengue13215.4 [4.3–42.2]KouroussaWNV13430.8 [12.7–57.6]Yellow_Fever13753.8 [29.1–76.8]Dengue951111.6 [6.6–19.6]LabeWNV953637.9 [28.8–47.9]Yellow_Fever951616.8 [10.6–25.6]Dengue1062018.9 [12.6–27.4]MamouWNV1063734.9 [26.5–44.4]Yellow_Fever1061817 [11–25.3]Dengue31013643.9 [38.5–49.4]N_ZerekoreWNV3107122.9 [18.6–27.9]Yellow_Fever310309.7 [6.9–13.5]Dengue4648.7 [3.4–20.3]PitaWNV461328.3 [17.3–42.5]Yellow_Fever46613 [6.1–25.7]Dengue35822.9 [12.1–39]SiguiriWNV351234.3 [20.8–50.8]Yellow_Fever351748.6 [33–64.4]Dengue8311.2 [0.2–6.5]TelemeleWNV8378.4 [4.1–16.4]Yellow_Fever832530.1 [21.3–40.7] Seroprevalence of ELISA-reactive antibodies to dengue virus, yellow fever virus, and West Nile virus by prefecture Distribution of seroreactivity to arboviruses across ecological zone An analysis of the distributions of ELISA-reactive antibodies to dengue, West Nile, and yellow fever viruses in Guinea’s four ecological zones (Lower Guinea, Forest Guinea, Upper Guinea, and Middle Guinea) revealed the presence of all three viruses. The seroprevalence of antibodies reactive to dengue virus was 13.7% [10.5–17.8], 24.8% [18–33.2], 36.1% [32.2–40.3], and 7.2% [5.6–9.2] in Middle Guinea, Upper Guinea, Forest Guinea, and Lower Guinea, respectively. Elevated seroprevalence estimates were observed in Upper Guinea and Forest Guinea. Seroprevalence estimates for yellow fever virus ranged from 9.1% [7–11.9] in Forest Guinea to 52.1% [43.2–60.8] in Upper Guinea, whereas those for WNV ranged from 17.5% [15–20.3] in Lower Guinea to 36.4% [28.3–45.2] in Upper Guinea. These results demonstrate the heterogeneity in the patterns of seroreactivity to these three viruses across Guinea’s ecological zones (Table 2).Table 2Proportion of ELISA-reactive samples to dengue virus, yellow fever virus, and West Nile virus by ecological zoneEcological zoneVirusN_testedPositiveProportions (%) [IC 95%]Lower GuineaDengue806587.2 [5.6–9.2]WNV80614117.5 [15–20.3]Yellow_Fever80629937.1 [33.8–40.5]Forest GuineaDengue53719436.1 [32.2–40.3]WNV53712222.7 [19.4–26.4]Yellow_Fever537499.1 [7–11.9]Upper GuineaDengue1213024.8 [18–33.2]WNV1214436.4 [28.3–45.2]Yellow_Fever1216352.1 [43.2–60.8]Middle GuineaDengue3424713.7 [10.5–17.8]WNV34212436.3 [31.3–41.5]Yellow_Fever3424713.7 [10.5–17.8] Table 2Proportion of ELISA-reactive samples to dengue virus, yellow fever virus, and West Nile virus by ecological zoneEcological zoneVirusN_testedPositiveProportions (%) [IC 95%]Lower GuineaDengue806587.2 [5.6–9.2]WNV80614117.5 [15–20.3]Yellow_Fever80629937.1 [33.8–40.5]Forest GuineaDengue53719436.1 [32.2–40.3]WNV53712222.7 [19.4–26.4]Yellow_Fever537499.1 [7–11.9]Upper GuineaDengue1213024.8 [18–33.2]WNV1214436.4 [28.3–45.2]Yellow_Fever1216352.1 [43.2–60.8]Middle GuineaDengue3424713.7 [10.5–17.8]WNV34212436.3 [31.3–41.5]Yellow_Fever3424713.7 [10.5–17.8] Proportion of ELISA-reactive samples to dengue virus, yellow fever virus, and West Nile virus by ecological zone Distribution of seroprevalence by age group for dengue virus, yellow fever virus, and West Nile virus The distribution of seroprevalence estimates by age group revealed variations in patterns of seroreactivity to arboviruses across age categories (Fig. 3). The highest seroprevalence of antibodies reactive to dengue virus was observed among people aged 25–64 years (22.4% [19.8–25.3%]). The seroprevalence of antibodies reactive to the seroprevalence of antibodies reactive to West Nile virus is relatively high among children aged 0–14 years (28.6% [23.5–34.3%]). Furthermore, seroprevalence estimates for antibodies reactive to yellow fever ranged from 18.8% [11.4–29.6] among adults aged 65 and older to 27.3% [24.5–30.3] among adults aged 25–64. These findings suggest age-related differences in exposure to, or seroreactivity against, these arboviruses.Fig. 3Proportion of samples reactive to dengue virus, yellow fever virus, and West Nile virus by age group Proportion of samples reactive to dengue virus, yellow fever virus, and West Nile virus by age group Patterns of multiple seroreactivity to dengue virus, yellow fever, and West Nile virus Analysis of the serological data revealed patterns of multiple reactivity to arboviruses in the human population (Fig. 4).The most frequently observed dual seroreactivity patterns involved yellow fever virus and West Nile virus, and dengue virus and yellow fever virus, with proportions of 17.1% [13.6–21.0] and 10.3% [7.4–13.8], respectively. Furthermore, concurrent seroreactivity to dengue virus and West Nile virus was less common, accounting for 3.0% [1.6–5.2]. Additionally, simultaneous seroreactivity to dengue virus, yellow fever virus and West Nil virus was observed in 2.3% [1.0–4.3%] of samples.Fig. 4Patterns of multiple seroreactivity to dengue virus, yellow fever virus, and West Nile virus in the human population Patterns of multiple seroreactivity to dengue virus, yellow fever virus, and West Nile virus in the human population Variation in seroprevalence by occupational category The Chi-square (χ2) analysis revealed a statistically significant association between cluster membership and all categorical variables examined, including occupation (p < 0.0001), professional group (p < 0.0001), age category (p = 1.35 × 10⁻3⁰⁷), sex (p = 1.54 × 10⁻11⁷), and locality (p = 4.67 × 10⁻5⁷), as well as serological markers such as dengue IgG (p = 1.55 × 10⁻14) and yellow fever IgG (p = 7.22 × 10⁻5). In cluster 3, the most represented occupations were homemakers (35.6%; p < 10⁻115), healthcare workers (18.7%), administrative staff (16.6%), and traders (13.5%). This cluster was predominantly associated with urban and peri-urban areas, including Conakry, Kindia, Mamou, and Labé. These localities also exhibited a relatively high seroreactivity to yellow fever (29.5%; p < 0.001). Cluster 4 was characterized by occupational groups such as farmers (38.4%; p < 10⁻11⁷), manual laborers (34.6%; p < 10⁻4⁰), and livestock breeders (13.6%; p < 10⁻3⁸). This group, composed predominantly of males (86.2%; p < 10⁻⁹⁸) and adults (mean age = 36.0 years; p < 10⁻2⁹), showed the highest seroreactivity to dengue (31.5%; p < 10⁻15). The highest seroreactivity estimates were observed in the prefectures of N’Zerekore (33.0%), Kissidougou (17.2%), and Gueckedou (9.4%). Clusters 1, 2, and 5 were characterized by a predominance of students, schoolchildren, and retirees, with comparatively lower seroreactivity to the studied viruses. These clusters were associated mainly with the prefectures of Siguiri, Dabola, Kankan, Kouroussa, and Dubreka (Figs. 5, 6, and 7).Fig. 5Cluster characterizationFig. 6Distribution of sex and seroprevalence by clusterFig. 7Distribution of prefectures and socioprofessional categories by cluster Cluster characterization Distribution of sex and seroprevalence by cluster Distribution of prefectures and socioprofessional categories by cluster Mosquito species diversity in Guinea A total of 3946 mosquitoes were collected. Analysis of species diversity revealed five Culicidae species in all prefectures (Conakry, Kindia, Kankan, Mamou, Labé, and N’Zerekore). The relative abundances of the different species varied by prefecture. The highest proportion of Aedes aegypti was found in N’Zerekore (16.27%), whereas the lowest proportion was found in Mamou (3.17%). Similarly, N'Zerekore recorded the highest proportion of the forest species Aedes vittatus (33.49%). Furthermore, Kankan is characterized by an abundance of Anopheles pharoensis, whereas Conakry is characterized by an abundance of Culex quinquefasciatus (44.22%). Additionally, Anopheles funestus was relatively more abundant in Kindia (32.56%). Overall, Culex quinquefasciatus was the most abundant species, followed by Anopheles funestus, Anopheles pharoensis, Aedes vittatus, and Aedes aegypti, with proportions of 32.36% [30.92–33.84], 24.84% [23.51–26.21], 18.12% [16.95–19.35], 16.22% [15.1–17.4], and 8.46% [7.64–9.37], respectively (Table 3).Table 3Mosquito diversity in selected prefectures of the Republic of GuineaSpeciesConakry ni (Pi)Kindia ni (Pi)Mamouni (Pi)Labe ni (Pi)Kankanni (Pi)N’Zerekoreni (Pi)Pi (CI 95%)Aedes aegypti40 (5.41)90 (10.98)18 (3.17)30 (6.12)54 (7.7)102(16.27)8.46[7.64–9.37]Aedes vittatus68 (9.19)115 (14.02)87 (15.32)70 (14.29)90 (12.84)210(33.49)16.22[15.1–17.4]Anopheles pharoensis146 (19.73)129 (15.73)98 (17.25)82 (16.73)206 (29.39)54 (8.61)18.12[16.95 -19.35]Culex quinquefasciatus305 (41.22)219 (26.71)270 (47.54)183 (37.35)144 (20.54)156 (24.88)32.36[30.92–33.84]Anopheles funestus181 (24.46)267 (32.56)95 (16.73)125 (25.51)207 (29.53)105 (16.75)24.84[23.51–26.21]Total740 (100)820 (100)568 (100)490 (100)701 (100)627 (100)3 946Taxa (S)555555NAni number, Pi proportion, CI confidence interval Table 3Mosquito diversity in selected prefectures of the Republic of GuineaSpeciesConakry ni (Pi)Kindia ni (Pi)Mamouni (Pi)Labe ni (Pi)Kankanni (Pi)N’Zerekoreni (Pi)Pi (CI 95%)Aedes aegypti40 (5.41)90 (10.98)18 (3.17)30 (6.12)54 (7.7)102(16.27)8.46[7.64–9.37]Aedes vittatus68 (9.19)115 (14.02)87 (15.32)70 (14.29)90 (12.84)210(33.49)16.22[15.1–17.4]Anopheles pharoensis146 (19.73)129 (15.73)98 (17.25)82 (16.73)206 (29.39)54 (8.61)18.12[16.95 -19.35]Culex quinquefasciatus305 (41.22)219 (26.71)270 (47.54)183 (37.35)144 (20.54)156 (24.88)32.36[30.92–33.84]Anopheles funestus181 (24.46)267 (32.56)95 (16.73)125 (25.51)207 (29.53)105 (16.75)24.84[23.51–26.21]Total740 (100)820 (100)568 (100)490 (100)701 (100)627 (100)3 946Taxa (S)555555NAni number, Pi proportion, CI confidence interval Mosquito diversity in selected prefectures of the Republic of Guinea 8.46 [7.64–9.37] 16.22 [15.1–17.4] 18.12 [16.95 -19.35] 32.36 [30.92–33.84] 24.84 [23.51–26.21] ni number, Pi proportion, CI confidence interval Assessment of arbovirus circulation in the vector mosquito population The results revealed infection in Culex quinquefasciatus at all locations. Kankan and N’Zerekore presented the highest infection rates, at 75% and 100%, respectively. Moreover, 33.3% and 50% of the collected Anopheles funestus specimens were also found to be infected with West Nile virus. No cases of infection were detected in Aedes aegypti, Aedes vittatus and Anopheles pharoensis (Table 4).Table 4Distribution of WNV infection rates within vector populationsSpeciesConakry% (n/N)Kindia%(n/N)Mamou%(n/N)Labe%(n/N)Kankan% (n/N)N_Zerekore % (n/N)Aedes aegypti0 (0/1)0(0/3)0 (0/1)0(0/1)0 (0/1)0 (0/3)Aedes vittatus0 (0/2)0(0/3)0(0/2)0(0/2)0(0/3)0(0/7)Anopheles pharoensis0 (0/4)0(0/4)0(0/3)0(0/2)0(0/6)0(0/1)Culex quinquefasciatus40 (4/10)28.6 (2/7)22.2 (2/9)16.7(1/6)75 (3/4)100 (5/5)Anopheles funestus33.3 (2/6)50 (3/6)0(0/3)0(0/4)0(0/6)(0/3)N: total number of pools tested at each location, n: number of pools in which the West Nile virus (WNV) was detected Table 4Distribution of WNV infection rates within vector populationsSpeciesConakry% (n/N)Kindia%(n/N)Mamou%(n/N)Labe%(n/N)Kankan% (n/N)N_Zerekore % (n/N)Aedes aegypti0 (0/1)0(0/3)0 (0/1)0(0/1)0 (0/1)0 (0/3)Aedes vittatus0 (0/2)0(0/3)0(0/2)0(0/2)0(0/3)0(0/7)Anopheles pharoensis0 (0/4)0(0/4)0(0/3)0(0/2)0(0/6)0(0/1)Culex quinquefasciatus40 (4/10)28.6 (2/7)22.2 (2/9)16.7(1/6)75 (3/4)100 (5/5)Anopheles funestus33.3 (2/6)50 (3/6)0(0/3)0(0/4)0(0/6)(0/3)N: total number of pools tested at each location, n: number of pools in which the West Nile virus (WNV) was detected Distribution of WNV infection rates within vector populations N: total number of pools tested at each location, n: number of pools in which the West Nile virus (WNV) was detected Discussion This study highlights the circulation of arboviruses across several prefectures in Guinea. It integrates serological and human entomological data to characterize the circulation of DENV, YFV, and WNV. Given the emergence and re-emergence of these arboviruses, these findings are essential for informing surveillance strategies. The serological findings suggest previous exposure to three arboviruses (DENV, YFV, and WNV) in the human population. Previous studies [25] have documented the circulation of arboviruses, including dengue and West Nile virus, in Guinea. In addition, more recent investigations by [26] have further confirmed the circulation of both dengue and West Nile virus within the human population in the Republic of Guinea. These results confirm the circulation of these viruses in the context of West Africa. Indeed, seroprevalence studies conducted in West Africa, particularly in Senegal, Burkina Faso, Togo, and Nigeria, have reported dengue virus circulation, and these countries are considered endemic [27–29]. The results suggest regular exposure rather than sporadic epidemic transmission. Furthermore, serological evidence of exposure to all three viruses was detected in the eighteen surveyed prefectures, suggesting a broad geographic distribution across Guinea. Higher seroprevalence was observed in Upper Guinea and Forest Guinea, which are broken down by the ecological zone. The broad geographic distribution of seropositivity may be partly related to the widespread distribution of competent vectors, particularly Aedes aegypti, throughout the country. The ability of these vectors to adapt and proliferate in humid tropical environments may contribute to the maintenance of arbovirus transmission in Guinea [19, 30–32]. The highest seroprevalence of dengue and yellow fever antibodies was observed among individuals aged 25–64 years. This pattern may be related to greater occupational and outdoor exposure among adults, given that the vectors responsible for these diseases are primarily diurnal [33]. These findings are consistent with those of Sautereau et al. [34], who demonstrated that most infections caused by these viruses occur in adults. Serological reactivity to more than one arbovirus was observed among some participants. Concurrent seropositivity for dengue and yellow fever virus, as well as yellow fever and West Nile virus may be related to the fact that both viruses share common mosquito vectors [35]. A significant association between dengue fever and yellow fever seropositivity was observed. Furthermore, higher seroprevalence was also found among livestock farmers, farmers and civil engineers than among healthcare workers and merchants. This trend can be explained by the fact that these diseases are transmitted by the same vectors and that the socioprofessional groups most affected are the ones most exposed to them. Livestock farmers, farmers and civil engineers often work outdoors, which increases their exposure to these exophagous, diurnal vectors and increases the risk of receiving an infectious bite [36]. Other studies have also shown that occupation can be a risk factor for arbovirus infection [37, 38]. The results regarding the diversity and abundance of vector species revealed that Culex quinquefasciatus was the most abundant, followed by Anopheles funestus, Anopheles pharoensis, Aedes vittatus, and Aedes aegypti. This diversity can be explained by the country’s ecological diversity, which is characterized by forested areas that are favorable to forest species, such as Aedes vittatus, and urban and densely populated environments that are favorable to Aedes aegypti. However, Culex can adapt to any environment, although it prefers polluted environments that provide it with organic matter [39–41]. This study investigated the seroprevalence and circulation of these viruses within the vector population to improve the understanding of the source of infections. The results demonstrated the circulation of VNV within the vector population. The simultaneous detection of VNV in humans and in the vector population is evidence of active, likely endemic, viral circulation in Guinea that has gone undetected owing to a lack of surveillance. These results highlight significant gaps in surveillance, as WNV is rarely considered in routine diagnostic algorithms for acute febrile illnesses in many African settings [42, 43]. The exclusive detection of WNV in Culex quinquefasciatus and Anopheles funestus further highlights the pivotal role of Culex species in WNV transmission. This phenomenon has been documented in certain African countries, including Senegal, Mauritania and South Africa [44, 45]. The particularly high detection rate of WNV in N’Zérékoré is also ecologically plausible [46, 47]. This forested region has environmental conditions conducive to the proliferation of vectors, including abundant rainfall, permanent wetlands, and dense bird populations. These characteristics are similar to those described in WNV circulation foci in Uganda, the Democratic Republic of the Congo, and southern Nigeria [48, 49]. The presence of the WNO virus in Anopheles funestus vectors, even in small proportions, warrants particular attention. Studies on this finding have been reported [50–52], suggesting that transient infection results from a contaminated blood meal or a potential secondary vector role. This study suggests widespread exposure to dengue, yellow fever, and West Nile viruses across the different regions of Guinea. These findings represent a significant public health concern, particularly in a context characterized by rapid ecological transformation and accelerated urban development in several cities driven by the Simandou 2040 program. The present work aligns with the strategic priorities of the Simandou 2040 program, which emphasizes disease prevention and control, as well as the strengthening of early warning systems for epidemic detection. Within this framework, arboviral diseases and emerging zoonotic infections are recognized as critical areas requiring sustained attention. Furthermore, ongoing environmental changes associated with mining activities, urban expansion, and consequent ecosystem alterations underscore the urgent need to establish robust surveillance systems to mitigate the risk of outbreaks. In this regard, the current study supports the objectives of the Simandou 2040 program by contributing to arbovirus surveillance efforts, with the aim of informing public health authorities about potential health risks and guiding the implementation of region-specific prevention strategies across the country. The absence of DENV and YFV in mosquitoes, despite their presence in the human population, may reflect seasonal dynamics. Continuous longitudinal surveillance would be necessary to characterize viral seasonality better. Overall, our results highlight the need to establish an integrated surveillance system that combines human serological monitoring, entomological surveillance, and environmental risk assessment. This would enhance our ability to detect threats early, guide targeted vector control interventions, and improve our preparedness against emerging and reemerging arboviral threats in West Africa. This study has several limitations that should be acknowledged. First, serological confirmation of positive samples using the Plaque Reduction Neutralization Test (PRNT), which is considered the reference method for differentiating arboviral infections, could not be performed. The use of this assay would have reduced the risk of cross-reactivity inherent to serological methods. In addition, the relatively limited number of serological samples available in some prefectures reduced the statistical power of geographic comparisons and may have affected the representativeness of seroprevalence estimates. Furthermore, entomological surveillance was not conducted in all prefectures included in the serological survey and did not account for seasonal variations, particularly between the dry and rainy seasons. These limitations may have led to an underestimation of the diversity and spatiotemporal dynamics of vector populations. This study could have enabled the identification of the viral lineages of West Nile virus circulating within mosquito vector populations, provided insights into potential introduction events, and facilitated comparisons between the detected strains and those circulating in other regions of West Africa. Conclusion This study highlights the significant exposure of the population of the Republic of Guinea to dengue virus (DENV), yellow fever virus (YFV) and West Nile virus (WNV). The detection of WNV RNA in mosquito vectors, particularly Culex quinquefasciatus, confirmed active viral circulation. Adult farmers and livestock keepers appear to be at the greatest risk of contracting dengue and yellow fever. These findings highlight the need to strengthen integrated arbovirus surveillance in Guinea by linking human serological monitoring with entomological investigations in order to enhance the timeliness of detection and response, thereby effectively supporting the public health objectives of the Simandou 2040 program.